KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.

  • Eli Lilly's Net Cash Flow rose 793349.69% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year increase of 78190.07%. This contributed to the annual value of $746.5 million for FY2024, which is 2804.46% up from last year.
  • As of Q3 2025, Eli Lilly's Net Cash Flow stood at $6.4 billion, which was up 793349.69% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's Net Cash Flow peaked at $6.4 billion during Q3 2025, and registered a low of -$1.4 billion during Q1 2022.
  • Its 5-year average for Net Cash Flow is $326.2 million, with a median of $7.1 million in 2025.
  • Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 1668947.37% in 2023, then soared by 793349.69% in 2025.
  • Eli Lilly's Net Cash Flow (Quarter) stood at $251.0 million in 2021, then crashed by 268.21% to -$422.2 million in 2022, then skyrocketed by 173.07% to $308.5 million in 2023, then grew by 6.29% to $327.9 million in 2024, then soared by 1847.03% to $6.4 billion in 2025.
  • Its Net Cash Flow stands at $6.4 billion for Q3 2025, versus $7.1 million for Q2 2025 and -$307.0 million for Q1 2025.